|
|
--- |
|
|
base_model: |
|
|
- TachyHealth/Gazal-R1-32B-sft-merged-preview |
|
|
datasets: |
|
|
- TachyHealth/medical_grpo |
|
|
- TachyHealth/structured_medical |
|
|
library_name: transformers |
|
|
license: apache-2.0 |
|
|
license_link: https://huggingface.co/TachyHealth/Gazal-R1-32B-GRPO-preview/blob/main/LICENSE |
|
|
pipeline_tag: text-generation |
|
|
tags: |
|
|
- gazal-r1 |
|
|
- grpo |
|
|
- qwen3 |
|
|
- conversational |
|
|
- medical |
|
|
- clinical |
|
|
- healthcare |
|
|
- reasoning |
|
|
--- |
|
|
|
|
|
# Gazal-R1-32B: Medical Reasoning Language Model |
|
|
|
|
|
The model was presented in the paper [Gazal-R1: Achieving State-of-the-Art Medical Reasoning with Parameter-Efficient Two-Stage Training](https://huggingface.co/papers/2506.21594). |
|
|
|
|
|
<a href="https://gazal.ai/" target="_blank" style="margin: 0px;"> |
|
|
<img alt="Gazal AI" src="./logo.png" style=" width: 70%;" /> |
|
|
</a> |
|
|
|
|
|
|
|
|
## Model Highlights |
|
|
|
|
|
Gazal-R1 is a state-of-the-art 32-billion-parameter language model specifically designed for medical reasoning and clinical decision-making. Built upon Qwen 3 32B, Gazal-R1 demonstrates that strategic training can enable mid-sized models to outperform significantly larger counterparts in specialized medical domains. |
|
|
|
|
|
Key features include: |
|
|
|
|
|
- **🔬 Medical Expertise**: Specialized training on 107,033 synthetic medical reasoning examples covering diagnostic reasoning, treatment planning, decision-making under uncertainty, and prognostic assessment |
|
|
- **🧠 Transparent Reasoning**: Structured clinical thinking with step-by-step explanations in `<think></think>` tags, following established clinical reasoning frameworks |
|
|
- **📊 State-of-the-Art Performance**: Achieves 87.1% on MedQA, 81.6% on MMLU Pro (Medical), and 79.6% on PubMedQA, surpassing models up to 12× larger |
|
|
- **⚡ Parameter Efficiency**: Advanced training techniques including Weight-Decomposed Low-Rank Adaptation (DoRA) and Rank-Stabilized LoRA (rsLoRA) |
|
|
- **🎯 Alignment Optimization**: Refined through Group Relative Policy Optimization (GRPO) with sophisticated multi-component reward systems |
|
|
- **🌍 Medical Knowledge**: Comprehensive understanding across multiple medical specialties and clinical scenarios |
|
|
|
|
|
## Model Overview |
|
|
|
|
|
**Gazal-R1-32B** has the following characteristics: |
|
|
- **Type**: Causal Language Model (Medical Reasoning Specialist) |
|
|
- **Base Model**: Qwen 3 32B |
|
|
- **Training Stages**: Two-stage pipeline (Supervised Fine-Tuning + Reinforcement Learning) |
|
|
- **Number of Parameters**: 32.8B |
|
|
- **Number of Parameters (Non-Embedding)**: 31.2B |
|
|
- **Context Length**: 32,768 tokens natively, extensible to 131,072 with YaRN |
|
|
- **Training Data**: 107,033 synthetic medical reasoning examples + [MedReason dataset](https://huggingface.co/datasets/UCSC-VLAA/MedReason) (32,682 examples) |
|
|
- **Fine-tuning Method**: DoRA + rsLoRA (Parameter-Efficient Fine-Tuning) |
|
|
- **Alignment**: Group Relative Policy Optimization (GRPO) |
|
|
|
|
|
For detailed methodology, training insights, and comprehensive evaluation, please refer to our [technical report](https://arxiv.org/abs/2506.21594). |
|
|
|
|
|
## Performance Results |
|
|
|
|
|
Gazal-R1 achieves exceptional performance across standard medical benchmarks: |
|
|
|
|
|
| Model | Size | MMLU Pro (Medical) | MedMCQA | MedQA | PubMedQA | |
|
|
|-------|------|-------------------|---------|-------|----------| |
|
|
| **Gazal-R1 (Final)** | **32B** | **81.6** | **71.9** | **87.1** | **79.6** | |
|
|
| [Gazal-R1 (SFT-only)](https://huggingface.co/TachyHealth/Gazal-R1-32B-sft-merged-preview) | 32B | 79.3 | 72.3 | 86.9 | 77.6 | |
|
|
| Llama 3.1 405B Instruct | 405B | 70.2 | 75.8 | 81.9 | 74.6 | |
|
|
| Qwen 2.5 72B Instruct | 72B | 72.1 | 66.2 | 72.7 | 71.7 | |
|
|
| Med42-Llama3.1-70B | 70B | 66.1 | 72.4 | 80.4 | 77.6 | |
|
|
| Llama 3.1 70B Instruct | 70B | 74.5 | 72.5 | 78.4 | 78.5 | |
|
|
| QwQ 32B | 32B | 70.1 | 65.6 | 72.3 | 73.7 | |
|
|
| Qwen 3 32B | 32B | 78.4 | 71.6 | 84.4 | 76.7 | |
|
|
|
|
|
**Key Achievements:** |
|
|
- 🥇 Highest scores on MMLU Pro (Medical), MedQA, and PubMedQA |
|
|
- 📈 Significant improvements from GRPO training (+2.3% on MMLU Pro, +2.0% on PubMedQA) |
|
|
- 🚀 Outperforms models up to 12× larger (Llama 3.1 405B) on medical reasoning tasks |
|
|
|
|
|
## Quickstart |
|
|
|
|
|
### Basic Usage |
|
|
|
|
|
```python |
|
|
from transformers import AutoModelForCausalLM, AutoTokenizer |
|
|
|
|
|
model_name = "TachyHealth/Gazal-R1-32B-GRPO-preview" |
|
|
|
|
|
# Load the tokenizer and model |
|
|
tokenizer = AutoTokenizer.from_pretrained(model_name) |
|
|
model = AutoModelForCausalLM.from_pretrained( |
|
|
model_name, |
|
|
torch_dtype="auto", |
|
|
device_map="auto" |
|
|
) |
|
|
|
|
|
# Medical reasoning prompt |
|
|
prompt = """A 65-year-old male presents with chest pain, shortness of breath, and elevated troponin levels. |
|
|
ECG shows ST-segment elevation in leads II, III, and aVF. What is the most likely diagnosis and immediate management?""" |
|
|
|
|
|
messages = [ |
|
|
{"role": "user", "content": prompt} |
|
|
] |
|
|
|
|
|
text = tokenizer.apply_chat_template( |
|
|
messages, |
|
|
tokenize=False, |
|
|
add_generation_prompt=True |
|
|
) |
|
|
|
|
|
model_inputs = tokenizer([text], return_tensors="pt").to(model.device) |
|
|
|
|
|
# Generate response with medical reasoning |
|
|
generated_ids = model.generate( |
|
|
**model_inputs, |
|
|
max_new_tokens=2048, |
|
|
temperature=0.7, |
|
|
top_p=0.8, |
|
|
top_k=20 |
|
|
) |
|
|
|
|
|
output_ids = generated_ids[0][len(model_inputs.input_ids[0]):].tolist() |
|
|
response = tokenizer.decode(output_ids, skip_special_tokens=True) |
|
|
|
|
|
print("Medical Assessment:", response) |
|
|
``` |
|
|
|
|
|
### Structured Medical Reasoning Format |
|
|
|
|
|
Gazal-R1 is trained to provide structured medical reasoning in the following format: |
|
|
|
|
|
``` |
|
|
<think> |
|
|
Step 1: Analyze presenting symptoms - chest pain, dyspnea, troponin elevation |
|
|
Step 2: Interpret ECG findings - ST elevation in inferior leads |
|
|
Step 3: Consider differential diagnoses - STEMI vs NSTEMI vs unstable angina |
|
|
Step 4: Identify culprit vessel - likely RCA given inferior lead changes |
|
|
Step 5: Assess urgency - emergent intervention required |
|
|
Step 6: Plan immediate management - dual antiplatelet, anticoagulation, cath lab |
|
|
</think> |
|
|
|
|
|
## Clinical Assessment |
|
|
|
|
|
**Primary Diagnosis**: ST-Elevation Myocardial Infarction (STEMI), inferior wall |
|
|
|
|
|
**Reasoning**: The combination of chest pain, elevated troponin, and ST-elevation in leads II, III, and aVF is pathognomonic for inferior STEMI, likely involving the right coronary artery (RCA). |
|
|
|
|
|
**Immediate Management**: |
|
|
1. **Reperfusion therapy**: Emergency cardiac catheterization with primary PCI |
|
|
2. **Antiplatelet therapy**: Aspirin 325mg + P2Y12 inhibitor (clopidogrel/ticagrelor) |
|
|
3. **Anticoagulation**: Heparin or bivalirudin |
|
|
4. **Supportive care**: O2 if hypoxic, nitroglycerin for pain (avoid if hypotensive) |
|
|
|
|
|
**Follow-up**: Post-PCI monitoring, echocardiogram, cardiac rehabilitation referral |
|
|
``` |
|
|
|
|
|
## Training Methodology |
|
|
|
|
|
### Stage 1: Supervised Fine-Tuning (SFT) |
|
|
- **Dataset**: 107,033 synthetic medical reasoning examples + [MedReason dataset](https://huggingface.co/datasets/UCSC-VLAA/MedReason) |
|
|
- **Techniques**: DoRA + rsLoRA with rank 256 |
|
|
- **Focus**: Structured clinical reasoning across diagnostic, therapeutic, and prognostic scenarios |
|
|
|
|
|
### Stage 2: Group Relative Policy Optimization (GRPO) |
|
|
- **Algorithm**: Value-function-free reinforcement learning |
|
|
- **Dataset**: UltraMedical subset (32K medical MCQs) |
|
|
- **Rewards**: Multi-component system (accuracy, format, length control, repetition penalty) |
|
|
- **Improvements**: Enhanced reasoning quality and format adherence |
|
|
|
|
|
## Model Capabilities |
|
|
|
|
|
### Clinical Reasoning Types |
|
|
1. **Diagnostic Reasoning**: Systematic symptom analysis → differential diagnosis |
|
|
2. **Treatment Planning**: Evidence-based therapy selection with patient-specific factors |
|
|
3. **Decision-Making Under Uncertainty**: Risk assessment and clinical judgment |
|
|
4. **Prognostic Assessment**: Outcome prediction based on clinical evidence |
|
|
|
|
|
### Medical Specialties Covered |
|
|
- Internal Medicine |
|
|
- Emergency Medicine |
|
|
- Cardiology |
|
|
- Pulmonology |
|
|
- Infectious Disease |
|
|
- Pharmacology |
|
|
- Pathophysiology |
|
|
- Clinical Laboratory Medicine |
|
|
|
|
|
## Limitations and Important Disclaimers |
|
|
|
|
|
### ⚠️ Critical Safety Information |
|
|
- **NOT A MEDICAL DEVICE**: Gazal-R1 is a research model and is **NOT** intended for direct clinical use, diagnosis, or treatment planning |
|
|
- **REQUIRES PROFESSIONAL VERIFICATION**: All outputs must be independently verified by qualified medical professionals |
|
|
- **NO REAL-TIME UPDATES**: Knowledge is static and does not reflect the latest medical research or guidelines |
|
|
|
|
|
### Technical Limitations |
|
|
- **Knowledge Cutoff**: Training data reflects medical knowledge up to the training date |
|
|
- **Hallucination Risk**: May generate plausible-sounding but factually incorrect information |
|
|
- **Evaluation Scope**: Primarily evaluated on multiple-choice questions; real-world clinical scenarios may differ |
|
|
- **Regional Bias**: Training data may contain geographical or demographic biases |
|
|
|
|
|
### Ethical Considerations |
|
|
- **Professional Responsibility**: Final medical decisions must always rest with qualified healthcare providers |
|
|
- **Accountability**: Users assume responsibility for verifying and appropriately applying model outputs |
|
|
- **Patient Safety**: Never use for emergency medical situations or time-critical decisions |
|
|
|
|
|
## Use Cases |
|
|
|
|
|
### Research and Education |
|
|
- Medical education and training |
|
|
- Clinical reasoning research |
|
|
- Medical knowledge assessment |
|
|
- Academic medical writing assistance |
|
|
|
|
|
### Professional Support (With Supervision) |
|
|
- Literature review assistance |
|
|
- Clinical case analysis support |
|
|
- Medical documentation aid |
|
|
- Differential diagnosis exploration |
|
|
|
|
|
### NOT Suitable For |
|
|
- Direct patient care |
|
|
- Emergency medical decisions |
|
|
- Replacing clinical judgment |
|
|
- Unsupervised medical advice |
|
|
|
|
|
## Citation |
|
|
|
|
|
If you find Gazal-R1 helpful in your research, please cite our work: |
|
|
|
|
|
```bibtex |
|
|
@article{gazal-r1-2025, |
|
|
title={Gazal-R1: Achieving State-of-the-Art Medical Reasoning with Parameter-Efficient Two-Stage Training}, |
|
|
author={Ahmed M. Adly and Mostafa Samy and Amr Fawzy}, |
|
|
journal={arXiv preprint arXiv:2506.21594}, |
|
|
year={2025}, |
|
|
url={https://arxiv.org/abs/2506.21594} |
|
|
} |
|
|
``` |
|
|
|
|
|
## Model Access |
|
|
|
|
|
- **Model Weights**: Available on Hugging Face Hub |
|
|
- **Datasets**: Training datasets available at [TachyHealth/structured_medical](https://huggingface.co/datasets/TachyHealth/structured_medical) and [TachyHealth/medical_grpo](https://huggingface.co/datasets/TachyHealth/medical_grpo) |
|
|
<!-- - **Technical Report**: [arXiv:2505.09388](https://arxiv.org/abs/2505.09388) --> |
|
|
|
|
|
## License |
|
|
|
|
|
This model is released under the Apache 2.0 License. Please review the license terms before use. |
|
|
|
|
|
## Contact |
|
|
|
|
|
For questions about Gazal-R1, please contact: |
|
|
- **Research Team**: TachyHealth |
|
|
- **Website**: [https://tachyhealth.com/](https://tachyhealth.com/) |
|
|
- **Gazal Platform**: [Gazal.ai](https://gazal.ai) |
|
|
|
|
|
--- |
|
|
|
|
|
*Developed by TachyHealth Research Team. This model represents a significant advancement in medical AI reasoning while emphasizing the critical importance of professional medical oversight.* |